Representative Scott Franklin Purchases Up to $95K in Novo Nordisk Stock

Representative Scott Franklin recently purchased Novo Nordisk stock valued between $18,004 and $95,000. This transaction occurred on August 4, 2025. Franklin has executed 234 trades over the past three years, totaling over $6.29 million. His recent trades include selling United Parcel Service and Comcast stock, and buying Novo Nordisk stock. Congressional transactions can be an important factor for investors to consider, as they may indicate a representative's expectations for a stock's performance.

Representative Scott Franklin recently purchased Novo Nordisk (NVO) stock valued between $18,004 and $95,000, according to an official report filed on August 14, 2025 [1]. This transaction took place on August 4, 2025, and comes amidst a period of significant trading activity by the Representative. Over the past three years, Franklin has executed 234 trades totaling over $6.29 million [1]. His recent trading activities include selling shares of United Parcel Service (UPS) and Comcast Corporation (CMCSA), and purchasing Novo Nordisk stock [1].

Congressional transactions, where representatives or senators buy or sell individual stocks, can provide insights into their expectations for a stock's performance. However, it is crucial to note that these transactions should not be the primary basis for investment decisions. The STOCK Act, signed into law in April 2012, prohibits members of Congress from using nonpublic information for personal gain, including stock trading [1].

The recent purchase of Novo Nordisk stock by Representative Franklin coincides with a pending class action lawsuit against the company. Faruqi & Faruqi, LLP has reminded investors that the deadline to seek the role of lead plaintiff in the lawsuit is September 30, 2025 [2]. The lawsuit alleges that Novo Nordisk made false or misleading statements and failed to disclose the true state of the company's growth potential [2].

The price of Novo Nordisk's common stock has been volatile recently. On July 28, 2025, the stock closed at $69.00 per share, but following the company's announcement of lowered sales and profit outlook on July 29, 2025, the price fell to $53.94 per share, a decline of about 21.83% [2].

While Representative Franklin's stock purchase might indicate his positive outlook on Novo Nordisk, investors should consider the broader market context and other factors influencing the stock's performance. The lawsuit and recent financial reports from the company may also impact the stock's price.

References:
[1] https://www.benzinga.com/insights/government/25/08/47158182/this-house-of-representative-just-bought-up-to-95k-in-novo-nordisk-stock
[2] https://www.morningstar.com/news/pr-newswire/20250815ny50959/faruqi-faruqi-reminds-novo-nordisk-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo